The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Strep Throat Treatment Drugs Market Research Report 2025
Synopsis
Penicillin or amoxicillin is the antibiotic of choice to treat group A strep pharyngitis. There has never been a report of a clinical isolate of group A strep that is resistant to penicillin. However, resistance to azithromycin and clarithromycin is common in some communities.
Global Strep Throat Treatment Drugs market is projected to reach US$ 2698.4 million in 2029, increasing from US$ 1986 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Strep Throat Treatment Drugs market research.
The strep throat treatment drugs market is driven by the prevalence of streptococcal infections and the need for effective treatment options. Strep throat is a common bacterial infection caused by Streptococcus bacteria, affecting millions of people worldwide. The rise in the incidence of strep throat and its potential complications, such as rheumatic fever and kidney damage, contribute to market growth. The market is propelled by the development of new and improved antibiotics and other therapeutics targeting streptococcal infections. However, the market also faces challenges, including antibiotic resistance, which poses a threat to treatment efficacy. Additionally, the difficulty in distinguishing between strep throat and viral infections, as well as the overuse of antibiotics, can pose obstacles for accurate diagnosis and appropriate treatment selection. To succeed, companies must focus on research and development to combat antibiotic resistance, collaborate with healthcare providers to improve diagnostic accuracy, and work towards providing targeted and effective strep throat treatment drugs to meet the increasing demand for effective therapeutic options.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Strep Throat Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Segment by Type
Penicillin
Amoxicillin
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Strep Throat Treatment Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Penicillin or amoxicillin is the antibiotic of choice to treat group A strep pharyngitis. There has never been a report of a clinical isolate of group A strep that is resistant to penicillin. However, resistance to azithromycin and clarithromycin is common in some communities.
Global Strep Throat Treatment Drugs market is projected to reach US$ 2698.4 million in 2029, increasing from US$ 1986 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Strep Throat Treatment Drugs market research.
The strep throat treatment drugs market is driven by the prevalence of streptococcal infections and the need for effective treatment options. Strep throat is a common bacterial infection caused by Streptococcus bacteria, affecting millions of people worldwide. The rise in the incidence of strep throat and its potential complications, such as rheumatic fever and kidney damage, contribute to market growth. The market is propelled by the development of new and improved antibiotics and other therapeutics targeting streptococcal infections. However, the market also faces challenges, including antibiotic resistance, which poses a threat to treatment efficacy. Additionally, the difficulty in distinguishing between strep throat and viral infections, as well as the overuse of antibiotics, can pose obstacles for accurate diagnosis and appropriate treatment selection. To succeed, companies must focus on research and development to combat antibiotic resistance, collaborate with healthcare providers to improve diagnostic accuracy, and work towards providing targeted and effective strep throat treatment drugs to meet the increasing demand for effective therapeutic options.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Strep Throat Treatment Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & co.
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
Astra Zeneca
Bayer
Bausch Health
Segment by Type
Penicillin
Amoxicillin
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Strep Throat Treatment Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Strep Throat Treatment Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Penicillin
1.2.3 Amoxicillin
1.3 Market by Application
1.3.1 Global Strep Throat Treatment Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Strep Throat Treatment Drugs Market Perspective (2018-2029)
2.2 Strep Throat Treatment Drugs Growth Trends by Region
2.2.1 Global Strep Throat Treatment Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Strep Throat Treatment Drugs Historic Market Size by Region (2018-2023)
2.2.3 Strep Throat Treatment Drugs Forecasted Market Size by Region (2024-2029)
2.3 Strep Throat Treatment Drugs Market Dynamics
2.3.1 Strep Throat Treatment Drugs Industry Trends
2.3.2 Strep Throat Treatment Drugs Market Drivers
2.3.3 Strep Throat Treatment Drugs Market Challenges
2.3.4 Strep Throat Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Strep Throat Treatment Drugs Players by Revenue
3.1.1 Global Top Strep Throat Treatment Drugs Players by Revenue (2018-2023)
3.1.2 Global Strep Throat Treatment Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Strep Throat Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Strep Throat Treatment Drugs Revenue
3.4 Global Strep Throat Treatment Drugs Market Concentration Ratio
3.4.1 Global Strep Throat Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Strep Throat Treatment Drugs Revenue in 2022
3.5 Strep Throat Treatment Drugs Key Players Head office and Area Served
3.6 Key Players Strep Throat Treatment Drugs Product Solution and Service
3.7 Date of Enter into Strep Throat Treatment Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Strep Throat Treatment Drugs Breakdown Data by Type
4.1 Global Strep Throat Treatment Drugs Historic Market Size by Type (2018-2023)
4.2 Global Strep Throat Treatment Drugs Forecasted Market Size by Type (2024-2029)
5 Strep Throat Treatment Drugs Breakdown Data by Application
5.1 Global Strep Throat Treatment Drugs Historic Market Size by Application (2018-2023)
5.2 Global Strep Throat Treatment Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Strep Throat Treatment Drugs Market Size (2018-2029)
6.2 North America Strep Throat Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Strep Throat Treatment Drugs Market Size by Country (2018-2023)
6.4 North America Strep Throat Treatment Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Strep Throat Treatment Drugs Market Size (2018-2029)
7.2 Europe Strep Throat Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Strep Throat Treatment Drugs Market Size by Country (2018-2023)
7.4 Europe Strep Throat Treatment Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Strep Throat Treatment Drugs Market Size (2018-2029)
8.2 Asia-Pacific Strep Throat Treatment Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Strep Throat Treatment Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Strep Throat Treatment Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Strep Throat Treatment Drugs Market Size (2018-2029)
9.2 Latin America Strep Throat Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Strep Throat Treatment Drugs Market Size by Country (2018-2023)
9.4 Latin America Strep Throat Treatment Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Strep Throat Treatment Drugs Market Size (2018-2029)
10.2 Middle East & Africa Strep Throat Treatment Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Strep Throat Treatment Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Strep Throat Treatment Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & co.
11.1.1 Merck & co. Company Detail
11.1.2 Merck & co. Business Overview
11.1.3 Merck & co. Strep Throat Treatment Drugs Introduction
11.1.4 Merck & co. Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.1.5 Merck & co. Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Strep Throat Treatment Drugs Introduction
11.2.4 Pfizer Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Strep Throat Treatment Drugs Introduction
11.3.4 Abbott Laboratories Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Strep Throat Treatment Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Strep Throat Treatment Drugs Introduction
11.5.4 Roche Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Strep Throat Treatment Drugs Introduction
11.6.4 Novartis Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Strep Throat Treatment Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Eli Lily
11.8.1 Eli Lily Company Detail
11.8.2 Eli Lily Business Overview
11.8.3 Eli Lily Strep Throat Treatment Drugs Introduction
11.8.4 Eli Lily Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.8.5 Eli Lily Recent Development
11.9 Astra Zeneca
11.9.1 Astra Zeneca Company Detail
11.9.2 Astra Zeneca Business Overview
11.9.3 Astra Zeneca Strep Throat Treatment Drugs Introduction
11.9.4 Astra Zeneca Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.9.5 Astra Zeneca Recent Development
11.10 Bayer
11.10.1 Bayer Company Detail
11.10.2 Bayer Business Overview
11.10.3 Bayer Strep Throat Treatment Drugs Introduction
11.10.4 Bayer Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.10.5 Bayer Recent Development
11.11 Bausch Health
11.11.1 Bausch Health Company Detail
11.11.2 Bausch Health Business Overview
11.11.3 Bausch Health Strep Throat Treatment Drugs Introduction
11.11.4 Bausch Health Revenue in Strep Throat Treatment Drugs Business (2018-2023)
11.11.5 Bausch Health Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
